Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 255,129,536
  • Shares Outstanding, K 2,532,806
  • Annual Sales, $ 60,115 M
  • Annual Income, $ 365,000 K
  • EBIT $ 14,160 M
  • EBITDA $ 18,032 M
  • 60-Month Beta 0.40
  • Price/Sales 4.28
  • Price/Cash Flow 33.49
  • Price/Book 5.91

Options Overview Details

View History
  • Implied Volatility 22.32% ( -1.89%)
  • Historical Volatility 16.46%
  • IV Percentile 79%
  • IV Rank 47.45%
  • IV High 30.32% on 10/28/24
  • IV Low 15.09% on 05/17/24
  • Put/Call Vol Ratio 1.99
  • Today's Volume 33,704
  • Volume Avg (30-Day) 34,014
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 425,902
  • Open Int (30-Day) 397,220

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.91
  • Number of Estimates 7
  • High Estimate 2.13
  • Low Estimate 1.82
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +6,266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.60 +2.16%
on 10/31/24
111.58 -9.72%
on 10/15/24
-9.04 (-8.24%)
since 10/04/24
3-Month
98.60 +2.16%
on 10/31/24
120.30 -16.27%
on 09/06/24
-10.42 (-9.37%)
since 08/06/24
52-Week
98.60 +2.16%
on 10/31/24
134.63 -25.18%
on 06/25/24
-3.61 (-3.46%)
since 11/06/23

Most Recent Stories

More News
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 69.27 (+10.65%)
BE : 10.97 (-3.77%)
CVX : 157.72 (+2.81%)
JPM : 247.06 (+11.54%)
MRK : 100.73 (-0.91%)
IHE : 68.39 (-0.52%)
PPH : 89.13 (-1.79%)
UNH : 596.69 (+5.23%)
PFE : 27.36 (-2.25%)
KBH : 79.91 (-2.57%)
XLE : 93.56 (+3.76%)
XHB : 117.48 (-0.95%)
2 Magnificent Stocks to Buy That Are Near 52-Week Lows

These stocks near 52-week lows could be ready to rebound.

MRK : 100.73 (-0.91%)
PFE : 27.36 (-2.25%)
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?

Moderna MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share,...

MRK : 100.73 (-0.91%)
MRNA : 51.81 (-2.78%)
GSK : 35.90 (-3.03%)
PFE : 27.36 (-2.25%)
Is This High-Yield Dividend Stock a Buy After Earnings?

This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.

$SPX : 5,929.04 (+2.53%)
MRK : 100.73 (-0.91%)
GCZ24 : 2,673.0 (-0.12%)
PFE : 27.36 (-2.25%)
Merck & Co. Stock: Is Wall Street Bullish or Bearish?

Despite Merck & Co.’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

XLV : 148.04 (+0.13%)
$SPX : 5,929.04 (+2.53%)
MRK : 100.73 (-0.91%)
Is Pfizer Stock a Bargain for Long-Term Investors?

Wall Street's bearish take on this proven innovator may not be warranted.

MRK : 100.73 (-0.91%)
PFE : 27.36 (-2.25%)
Is It Time to Buy October's Worst-Performing Dow Jones Stocks?

The Dow finished October down slightly. Should you buy any of these blue chips?

MSFT : 420.18 (+2.12%)
MRK : 100.73 (-0.91%)
NKE : 75.32 (-3.41%)
DOW : 48.35 (+0.94%)
3 Magnificent Stocks Under $100 to Buy in November

The price could be right for these stocks.

AZN : 63.85 (-3.65%)
SMMT : 20.89 (+2.45%)
MRK : 100.73 (-0.91%)
EXEL : 35.51 (+2.13%)
2 Dividend Stocks to Buy for a Lifetime of Passive Income

These are the kinds of stocks that can allow investors to sleep easy at night.

MRK : 100.73 (-0.91%)
SMMT : 20.89 (+2.45%)
MDT : 90.11 (+0.48%)
MRNA : 51.81 (-2.78%)
ISRG : 515.55 (+0.07%)
Is Merck Stock a Buy?

The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.

MRK : 100.73 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 105.07
2nd Resistance Point 104.15
1st Resistance Point 102.44
Last Price 100.73
1st Support Level 99.81
2nd Support Level 98.89
3rd Support Level 97.18

See More

52-Week High 134.63
Fibonacci 61.8% 120.87
Fibonacci 50% 116.62
Fibonacci 38.2% 112.36
Last Price 100.73
52-Week Low 98.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar